Philip A. van Damme
Fundador en Stichting Sanammad .
Cargos activos de Philip A. van Damme
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Stichting Sanammad | Director/Miembro de la Junta | 01/01/2009 | - |
| Fundador | 01/01/2009 | - | |
| Presidente | 01/01/2009 | - | |
| Sanammad Pharmaceuticals BV | Director/Miembro de la Junta | 01/01/2014 | - |
| Fundador | 01/01/2014 | - | |
| Presidente | 01/01/2014 | - |
Historial de carrera de Philip A. van Damme
Antiguos cargos conocidos de Philip A. van Damme.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Director/Miembro de la Junta | 01/05/2014 | 06/05/2020 |
| Director Técnico/Científico/I+D | 01/05/2014 | 06/05/2020 | |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Director/Miembro de la Junta | 01/01/2012 | - |
| Director Técnico/Científico/I+D | 30/07/2013 | - |
Formación de Philip A. van Damme.
| University of Utrecht | Doctorate Degree |
Estadísticas
Internacional
| Países Bajos | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV |
- Bolsa de valores
- Insiders
- Philip A. van Damme
- Experiencia
